Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Show more

Location: 3222 Phoenixville Pike, Malvern, PA, 19355, United States | Website: https://neurostar.com | Industry: Medical Devices | Sector: Healthcare


Market Cap

259.2M

52 Wk Range

$0.52 - $5.92

Previous Close

$3.92

Open

$3.92

Volume

1,557,701

Day Range

$3.80 - $4.00

Enterprise Value

333.3M

Cash

10.97M

Avg Qtr Burn

-8.628M

Insider Ownership

9.43%

Institutional Own.

63.17%

Qtr Updated

06/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date